Overview of the Personalized Medicine (PM) Solution market report The Personalized Medicine (PM) Solution market study was conducted using primary and secondary data, as described in the industry report. This report's main goal is to forecast growth and trends in the worldwide Personalized Medicine (PM) Solution market and present those projections to the clients to assist them in making critical decisions. In our analysis on the worldwide global Personalized Medicine (PM) Solution market, key market participants from all over the world are thoroughly studied and well-documented. Our comprehensive assessment of the Personalized Medicine (PM) Solution market report of the Software & Services industry focuses on a number of key topics, including market growth drivers, consumer behaviour patterns, revenues, manufacturing costs, leading players' sales trends, and much more. The four main categories of our Personalized Medicine (PM) Solution market report are type, application, end-use industry, and geographic location/region. Our worldwide Personalized Medicine (PM) Solution market report's primary goal is to provide thorough, reliable research to clients, consumers, and both emerging and established firms in the Personalized Medicine (PM) Solution industry. Leading Segments Personalized Medicine (PM) Solution market The Personalized Medicine (PM) Solution market report analyses the major market segments that are divided by type, application, end-user industry, and region in order to determine the market size and CAGR in the future period. The study offers an accurate and circumstantial research into the development, growth, trends, and most recent developments in the Personalized Medicine (PM) Solution market through extensive segmentation and explanation of each segment. Our analysis on the worldwide Personalized Medicine (PM) Solution market emphasizes the qualitative aspects of the industry in addition to its quantitative aspects. Our worldwide Personalized Medicine (PM) Solution market study goes in-depth on aspects like internal, external, and natural factors that could impede or affect the market's growth. The research also covers the current state of the world's Personalized Medicine (PM) Solution market, the top manufacturers' products, and investment prospects for various parties. In our assessment of the Personalized Medicine (PM) Solution market, we also include the newest and most promising trends in each area. The top manufacturers and other key players in the global Personalized Medicine (PM) Solution market: 2bPrecise OneOme TIGAR Health- IR2Dx Kailos Genetics Syapse Inc Karius Astarte Medical Fabric Genomics, INC. Orion Health 2B Precise Fabric Genomics Pfizer Gene 42 IBM Watson Health Philips Healthcare Medtronic Nanthealth Navican N-of-One PierianDx Sunquest Information System Tempus Novartis Translational Software Biocrates Life Sciences AG Nanostring Technologies Thermo Fisher Scientific Quest Diagnostics Incorporated Segmentation of the Personalized Medicine (PM) Solution market on the basis of Type: Personalized Diagnostics Personalized Therapies Personalized Nutrition & Wellness Segmentation of the Personalized Medicine (PM) Solution market on the basis of Application: Oncology Neurosciences Immunology Respiratory Others Global Personalized Medicine (PM) Solution Market Regional Analysis:
Regions | Sub Regions |
---|---|
North America | USA, Canada and Mexico etc. |
Asia-Pacific | China, Japan, Korea, India, and Southeast Asia |
The Middle East and Africa | Saudi Arabia, the UAE, Egypt, Turkey, Nigeria, and South Africa |
Europe | Germany, France, the UK, Russia, and Italy |
South America | Brazil, Argentina, Columbia, etc. |
Table of Contents 1 Market Overview 1.1 Product Overview and Scope of Personalized Medicine (PM) Solution 1.2 Classification of Personalized Medicine (PM) Solution by Type 1.2.1 Overview: Global Personalized Medicine (PM) Solution Market Size by Type: 2020 Versus 2021 Versus 2026 1.2.2 Global Personalized Medicine (PM) Solution Revenue Market Share by Type in 2020 1.2.3 Personalized Diagnostics 1.2.4 Personalized Therapies 1.2.5 Personalized Nutrition & Wellness 1.3 Global Personalized Medicine (PM) Solution Market by Application 1.3.1 Overview: Global Personalized Medicine (PM) Solution Market Size by Application: 2020 Versus 2021 Versus 2026 1.3.2 Oncology 1.3.3 Neurosciences 1.3.4 Immunology 1.3.5 Respiratory 1.3.6 Others
Table of Contents 1 Market Overview 1.1 Product Overview and Scope of Personalized Medicine (PM) Solution 1.2 Classification of Personalized Medicine (PM) Solution by Type 1.2.1 Overview: Global Personalized Medicine (PM) Solution Market Size by Type: 2020 Versus 2021 Versus 2026 1.2.2 Global Personalized Medicine (PM) Solution Revenue Market Share by Type in 2020 1.2.3 Personalized Diagnostics 1.2.4 Personalized Therapies 1.2.5 Personalized Nutrition & Wellness 1.3 Global Personalized Medicine (PM) Solution Market by Application 1.3.1 Overview: Global Personalized Medicine (PM) Solution Market Size by Application: 2020 Versus 2021 Versus 2026 1.3.2 Oncology 1.3.3 Neurosciences 1.3.4 Immunology 1.3.5 Respiratory 1.3.6 Others 1.4 Global Personalized Medicine (PM) Solution Market Size & Forecast 1.5 Global Personalized Medicine (PM) Solution Market Size and Forecast by Region 1.5.1 Global Personalized Medicine (PM) Solution Market Size by Region: 2016 VS 2021 VS 2026 1.5.2 Global Personalized Medicine (PM) Solution Market Size by Region, (2016-2021) 1.5.3 North America Personalized Medicine (PM) Solution Market Size and Prospect (2020-2030) 1.5.4 Europe Personalized Medicine (PM) Solution Market Size and Prospect (2020-2030) 1.5.5 Asia-Pacific Personalized Medicine (PM) Solution Market Size and Prospect (2020-2030) 1.5.6 South America Personalized Medicine (PM) Solution Market Size and Prospect (2020-2030) 1.5.7 Middle East and Africa Personalized Medicine (PM) Solution Market Size and Prospect (2020-2030) 1.6 Market Drivers, Restraints and Trends 1.6.1 Personalized Medicine (PM) Solution Market Drivers 1.6.2 Personalized Medicine (PM) Solution Market Restraints 1.6.3 Personalized Medicine (PM) Solution Trends Analysis 2 Company Profiles 2.1 2bPrecise 2.1.1 2bPrecise Details 2.1.2 2bPrecise Major Business 2.1.3 2bPrecise Personalized Medicine (PM) Solution Product and Solutions 2.1.4 2bPrecise Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.1.5 2bPrecise Recent Developments and Future Plans 2.2 OneOme 2.2.1 OneOme Details 2.2.2 OneOme Major Business 2.2.3 OneOme Personalized Medicine (PM) Solution Product and Solutions 2.2.4 OneOme Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.2.5 OneOme Recent Developments and Future Plans 2.3 TIGAR Health- IR2Dx 2.3.1 TIGAR Health- IR2Dx Details 2.3.2 TIGAR Health- IR2Dx Major Business 2.3.3 TIGAR Health- IR2Dx Personalized Medicine (PM) Solution Product and Solutions 2.3.4 TIGAR Health- IR2Dx Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.3.5 TIGAR Health- IR2Dx Recent Developments and Future Plans 2.4 Kailos Genetics 2.4.1 Kailos Genetics Details 2.4.2 Kailos Genetics Major Business 2.4.3 Kailos Genetics Personalized Medicine (PM) Solution Product and Solutions 2.4.4 Kailos Genetics Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.4.5 Kailos Genetics Recent Developments and Future Plans 2.5 Syapse Inc 2.5.1 Syapse Inc Details 2.5.2 Syapse Inc Major Business 2.5.3 Syapse Inc Personalized Medicine (PM) Solution Product and Solutions 2.5.4 Syapse Inc Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.5.5 Syapse Inc Recent Developments and Future Plans 2.6 Karius 2.6.1 Karius Details 2.6.2 Karius Major Business 2.6.3 Karius Personalized Medicine (PM) Solution Product and Solutions 2.6.4 Karius Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.6.5 Karius Recent Developments and Future Plans 2.7 Astarte Medical 2.7.1 Astarte Medical Details 2.7.2 Astarte Medical Major Business 2.7.3 Astarte Medical Personalized Medicine (PM) Solution Product and Solutions 2.7.4 Astarte Medical Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.7.5 Astarte Medical Recent Developments and Future Plans 2.8 Fabric Genomics, INC. 2.8.1 Fabric Genomics, INC. Details 2.8.2 Fabric Genomics, INC. Major Business 2.8.3 Fabric Genomics, INC. Personalized Medicine (PM) Solution Product and Solutions 2.8.4 Fabric Genomics, INC. Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.8.5 Fabric Genomics, INC. Recent Developments and Future Plans 2.9 Orion Health 2.9.1 Orion Health Details 2.9.2 Orion Health Major Business 2.9.3 Orion Health Personalized Medicine (PM) Solution Product and Solutions 2.9.4 Orion Health Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.9.5 Orion Health Recent Developments and Future Plans 2.10 2B Precise 2.10.1 2B Precise Details 2.10.2 2B Precise Major Business 2.10.3 2B Precise Personalized Medicine (PM) Solution Product and Solutions 2.10.4 2B Precise Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.10.5 2B Precise Recent Developments and Future Plans 2.11 Fabric Genomics 2.11.1 Fabric Genomics Details 2.11.2 Fabric Genomics Major Business 2.11.3 Fabric Genomics Personalized Medicine (PM) Solution Product and Solutions 2.11.4 Fabric Genomics Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.11.5 Fabric Genomics Recent Developments and Future Plans 2.12 Pfizer 2.12.1 Pfizer Details 2.12.2 Pfizer Major Business 2.12.3 Pfizer Personalized Medicine (PM) Solution Product and Solutions 2.12.4 Pfizer Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.12.5 Pfizer Recent Developments and Future Plans 2.13 Gene 42 2.13.1 Gene 42 Details 2.13.2 Gene 42 Major Business 2.13.3 Gene 42 Personalized Medicine (PM) Solution Product and Solutions 2.13.4 Gene 42 Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.13.5 Gene 42 Recent Developments and Future Plans 2.14 IBM Watson Health 2.14.1 IBM Watson Health Details 2.14.2 IBM Watson Health Major Business 2.14.3 IBM Watson Health Personalized Medicine (PM) Solution Product and Solutions 2.14.4 IBM Watson Health Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.14.5 IBM Watson Health Recent Developments and Future Plans 2.15 Philips Healthcare 2.15.1 Philips Healthcare Details 2.15.2 Philips Healthcare Major Business 2.15.3 Philips Healthcare Personalized Medicine (PM) Solution Product and Solutions 2.15.4 Philips Healthcare Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.15.5 Philips Healthcare Recent Developments and Future Plans 2.16 Medtronic 2.16.1 Medtronic Details 2.16.2 Medtronic Major Business 2.16.3 Medtronic Personalized Medicine (PM) Solution Product and Solutions 2.16.4 Medtronic Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.16.5 Medtronic Recent Developments and Future Plans 2.17 Nanthealth 2.17.1 Nanthealth Details 2.17.2 Nanthealth Major Business 2.17.3 Nanthealth Personalized Medicine (PM) Solution Product and Solutions 2.17.4 Nanthealth Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.17.5 Nanthealth Recent Developments and Future Plans 2.18 Navican 2.18.1 Navican Details 2.18.2 Navican Major Business 2.18.3 Navican Personalized Medicine (PM) Solution Product and Solutions 2.18.4 Navican Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.18.5 Navican Recent Developments and Future Plans 2.19 N-of-One 2.19.1 N-of-One Details 2.19.2 N-of-One Major Business 2.19.3 N-of-One Personalized Medicine (PM) Solution Product and Solutions 2.19.4 N-of-One Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.19.5 N-of-One Recent Developments and Future Plans 2.20 PierianDx 2.20.1 PierianDx Details 2.20.2 PierianDx Major Business 2.20.3 PierianDx Personalized Medicine (PM) Solution Product and Solutions 2.20.4 PierianDx Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.20.5 PierianDx Recent Developments and Future Plans 2.21 Sunquest Information System 2.21.1 Sunquest Information System Details 2.21.2 Sunquest Information System Major Business 2.21.3 Sunquest Information System Personalized Medicine (PM) Solution Product and Solutions 2.21.4 Sunquest Information System Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.21.5 Sunquest Information System Recent Developments and Future Plans 2.22 Tempus 2.22.1 Tempus Details 2.22.2 Tempus Major Business 2.22.3 Tempus Personalized Medicine (PM) Solution Product and Solutions 2.22.4 Tempus Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.22.5 Tempus Recent Developments and Future Plans 2.23 Novartis 2.23.1 Novartis Details 2.23.2 Novartis Major Business 2.23.3 Novartis Personalized Medicine (PM) Solution Product and Solutions 2.23.4 Novartis Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.23.5 Novartis Recent Developments and Future Plans 2.24 Translational Software 2.24.1 Translational Software Details 2.24.2 Translational Software Major Business 2.24.3 Translational Software Personalized Medicine (PM) Solution Product and Solutions 2.24.4 Translational Software Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.24.5 Translational Software Recent Developments and Future Plans 2.25 Biocrates Life Sciences AG 2.25.1 Biocrates Life Sciences AG Details 2.25.2 Biocrates Life Sciences AG Major Business 2.25.3 Biocrates Life Sciences AG Personalized Medicine (PM) Solution Product and Solutions 2.25.4 Biocrates Life Sciences AG Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.25.5 Biocrates Life Sciences AG Recent Developments and Future Plans 2.26 Nanostring Technologies 2.26.1 Nanostring Technologies Details 2.26.2 Nanostring Technologies Major Business 2.26.3 Nanostring Technologies Personalized Medicine (PM) Solution Product and Solutions 2.26.4 Nanostring Technologies Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.26.5 Nanostring Technologies Recent Developments and Future Plans 2.27 Thermo Fisher Scientific 2.27.1 Thermo Fisher Scientific Details 2.27.2 Thermo Fisher Scientific Major Business 2.27.3 Thermo Fisher Scientific Personalized Medicine (PM) Solution Product and Solutions 2.27.4 Thermo Fisher Scientific Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.27.5 Thermo Fisher Scientific Recent Developments and Future Plans 2.28 Quest Diagnostics Incorporated 2.28.1 Quest Diagnostics Incorporated Details 2.28.2 Quest Diagnostics Incorporated Major Business 2.28.3 Quest Diagnostics Incorporated Personalized Medicine (PM) Solution Product and Solutions 2.28.4 Quest Diagnostics Incorporated Personalized Medicine (PM) Solution Revenue, Gross Margin and Market Share (2019-2021) 2.28.5 Quest Diagnostics Incorporated Recent Developments and Future Plans 3 Market Competition, by Players 3.1 Global Personalized Medicine (PM) Solution Revenue and Share by Players (2019-2021) 3.2 Market Concentration Rate 3.2.1 Top 3 Personalized Medicine (PM) Solution Players Market Share 3.2.2 Top 10 Personalized Medicine (PM) Solution Players Market Share 3.2.3 Market Competition Trend 3.3 Personalized Medicine (PM) Solution Players Head Office, Products and Services Provided 3.4 Mergers & Acquisitions 3.5 New Entrants and Expansion Plans 4 Market Size Segment by Type 4.1 Global Personalized Medicine (PM) Solution Revenue and Market Share by Type (2016-2021) 4.2 Global Personalized Medicine (PM) Solution Market Forecast by Type (2021-2026) 5 Market Size Segment by Application 5.1 Global Personalized Medicine (PM) Solution Revenue Market Share by Application (2016-2021) 5.2 Personalized Medicine (PM) Solution Market Forecast by Application (2021-2026) 6 North America by Country, by Type, and by Application 6.1 North America Personalized Medicine (PM) Solution Revenue by Type (2020-2030) 6.2 North America Personalized Medicine (PM) Solution Revenue by Application (2020-2030) 6.3 North America Personalized Medicine (PM) Solution Market Size by Country 6.3.1 North America Personalized Medicine (PM) Solution Revenue by Country (2020-2030) 6.3.2 United States Personalized Medicine (PM) Solution Market Size and Forecast (2020-2030) 6.3.3 Canada Personalized Medicine (PM) Solution Market Size and Forecast (2020-2030) 6.3.4 Mexico Personalized Medicine (PM) Solution Market Size and Forecast (2020-2030) 7 Europe by Country, by Type, and by Application 7.1 Europe Personalized Medicine (PM) Solution Revenue by Type (2020-2030) 7.2 Europe Personalized Medicine (PM) Solution Revenue by Application (2020-2030) 7.3 Europe Personalized Medicine (PM) Solution Market Size by Country 7.3.1 Europe Personalized Medicine (PM) Solution Revenue by Country (2020-2030) 7.3.2 Germany Personalized Medicine (PM) Solution Market Size and Forecast (2020-2030) 7.3.3 France Personalized Medicine (PM) Solution Market Size and Forecast (2020-2030) 7.3.4 United Kingdom Personalized Medicine (PM) Solution Market Size and Forecast (2020-2030) 7.3.5 Russia Personalized Medicine (PM) Solution Market Size and Forecast (2020-2030) 7.3.6 Italy Personalized Medicine (PM) Solution Market Size and Forecast (2020-2030) 8 Asia-Pacific by Region, by Type, and by Application 8.1 Asia-Pacific Personalized Medicine (PM) Solution Revenue by Type (2020-2030) 8.2 Asia-Pacific Personalized Medicine (PM) Solution Revenue by Application (2020-2030) 8.3 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Region 8.3.1 Asia-Pacific Personalized Medicine (PM) Solution Revenue by Region (2020-2030) 8.3.2 China Personalized Medicine (PM) Solution Market Size and Forecast (2020-2030) 8.3.3 Japan Personalized Medicine (PM) Solution Market Size and Forecast (2020-2030) 8.3.4 South Korea Personalized Medicine (PM) Solution Market Size and Forecast (2020-2030) 8.3.5 India Personalized Medicine (PM) Solution Market Size and Forecast (2020-2030) 8.3.6 Southeast Asia Personalized Medicine (PM) Solution Market Size and Forecast (2020-2030) 8.3.7 Australia Personalized Medicine (PM) Solution Market Size and Forecast (2020-2030) 9 South America by Country, by Type, and by Application 9.1 South America Personalized Medicine (PM) Solution Revenue by Type (2020-2030) 9.2 South America Personalized Medicine (PM) Solution Revenue by Application (2020-2030) 9.3 South America Personalized Medicine (PM) Solution Market Size by Country 9.3.1 South America Personalized Medicine (PM) Solution Revenue by Country (2020-2030) 9.3.2 Brazil Personalized Medicine (PM) Solution Market Size and Forecast (2020-2030) 9.3.3 Argentina Personalized Medicine (PM) Solution Market Size and Forecast (2020-2030) 10 Middle East & Africa by Country, by Type, and by Application 10.1 Middle East & Africa Personalized Medicine (PM) Solution Revenue by Type (2020-2030) 10.2 Middle East & Africa Personalized Medicine (PM) Solution Revenue by Application (2020-2030) 10.3 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Country 10.3.1 Middle East & Africa Personalized Medicine (PM) Solution Revenue by Country (2020-2030) 10.3.2 Turkey Personalized Medicine (PM) Solution Market Size and Forecast (2020-2030) 10.3.3 Saudi Arabia Personalized Medicine (PM) Solution Market Size and Forecast (2020-2030) 10.3.4 UAE Personalized Medicine (PM) Solution Market Size and Forecast (2020-2030) 11 Research Findings and Conclusion 12 Appendix 12.1 Methodology 12.2 Research Process and Data Source 12.3 Disclaimer